This call for abstracts affords an exciting opportunity to highlight cancer stem cell focused research, providing a forum to showcase basic research, as well as novel technologies and translational therapeutic strategies.
Who should submit?
- Basic science researchers
- Clinical researchers
- Translational researchers
- Developmental Biology
- Immune Interaction
- Cellular Metabolism
- Epigenetic Regulation
- Druggable Targets
- Emerging Technologies
What is the abstract format?
- Microsoft Word document
- 300 words maximum (excluding title, authors and institutions)
- 11 point Arial font
- Margins: 1 inch
- Abstract title: bold and centered
- Corresponding author: Name, email address
- Avoid special characters
- Exclude references, drawings and graphs
How do I submit my abstract?
How are abstracts reviewed?
Submissions will be reviewed by the program committee and/or selected experts. Submissions will be evaluated based on the overall quality, methods used and relevance to symposia topics.
What is the submission deadline?
Abstracts must be submitted electronically via the button above by 5 pm EST on June 8, 2022.
Who should I contact if I have questions or wish to withdraw my submission?
Contact the Case Comprehensive Cancer Center Events Team (firstname.lastname@example.org) with any questions. If you choose to withdraw your abstract, send an email to email@example.com no later than June 30, 2022.